NEU 1.15% $20.62 neuren pharmaceuticals limited

Ann: P2 trial shows significant improvements in Phelan-McDermid, page-206

  1. 2,165 Posts.
    lightbulb Created with Sketch. 567
    Yes GC, crucial point for Neu is not only maximising $$ value for the asset but fast tracking to ph3’s.

    Which leads me to think our discussions re our future are well advanced.

    Interestingly partnering with big pharma might not be ideal or TO as Neu would not be able to drive this out come.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.62
Change
-0.240(1.15%)
Mkt cap ! $2.635B
Open High Low Value Volume
$20.45 $20.62 $20.26 $4.698M 229.0K

Buyers (Bids)

No. Vol. Price($)
1 221 $20.60
 

Sellers (Offers)

Price($) Vol. No.
$20.62 1553 1
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.